Table 1.
Distribution of serum samples from patients groups with and without loxoscelism
| Age group | Without loxoscelisma (n = 30) | With loxoscelisma | ||||
|---|---|---|---|---|---|---|
| Cutaneousb (n = 6) | Systemicb (n = 4) | |||||
| Male | Female | Male | Female | Male | Female | |
| 18–29 | 11/36.7% | 16/53.3% | 1/16.7% | 2/33.3% | 2/50% | 1/25% |
| 30–60 | 3/10% | – | 2/33.3% | 1/16.7% | – | 1/25% |
aSamples of serum obtained under informed consent (procedure approved by the Research Ethics Committee of the Universidad de Antofagasta – CEIC-UA)
bAccording to clinical history and/or direct observation of dermonecrotic lesion. Samples are represented as number and percentage (n/%)